MedPath

JELIKALITE LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Transcranial Photobiomodulation for Reducing Autism Symptoms in Children - Open Label Study (TPBMASDOL)

Not Applicable
Completed
Conditions
Autism Spectrum Disorder
First Posted Date
2024-04-11
Last Posted Date
2024-06-06
Lead Sponsor
JelikaLite LLC
Target Recruit Count
25
Registration Number
NCT06359080
Locations
🇺🇸

Dr. Steingold Psychology PC, New York, New York, United States

Transcranial Photobiomodulation for Reducing Autism Symptoms in Children

Not Applicable
Completed
Conditions
Autism Spectrum Disorder
First Posted Date
2020-12-09
Last Posted Date
2024-06-03
Lead Sponsor
JelikaLite LLC
Target Recruit Count
34
Registration Number
NCT04660552
Locations
🇺🇸

Dr. Steingold Psychology PC, New York, New York, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.